Terms: = Testicular cancer AND AFP, AFPD, FETA, HPAFP AND Staging
67 results:
1. Εmerging Biomarkers in the Diagnosis and Treatment of testicular Tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract] [Full Text] [Related]
2. testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.
Dieckmann KP; Dumlupinar C; Grobelny F; Utschig J; Klemke M; Ahmed Saad EM; Wülfing C; Pichlmeier U; Isbarn H; Belge G
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7079-7090. PubMed ID: 36869885
[TBL] [Abstract] [Full Text] [Related]
3. French AFU cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
[TBL] [Abstract] [Full Text] [Related]
4. Serum tumour markers in germ cell tumours: From diagnosis to cure.
Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
[TBL] [Abstract] [Full Text] [Related]
5. [French ccAFU guidelines - update 2020-2022: testicular germ cell tumors].
Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
Prog Urol; 2020 Nov; 30(12S):S280-S313. PubMed ID: 33349427
[TBL] [Abstract] [Full Text] [Related]
6. 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
Aydos U; Tahtaci G; Özgür Akdemir Ü; Özet A
Nucl Med Commun; 2020 Nov; 41(11):1199-1209. PubMed ID: 32796455
[TBL] [Abstract] [Full Text] [Related]
7. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
[TBL] [Abstract] [Full Text] [Related]
8. Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.
Kollmannsberger CK; Nappi L; Nichols C
J Clin Oncol; 2019 Aug; 37(22):1856-1862. PubMed ID: 31180818
[No Abstract] [Full Text] [Related]
9. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract] [Full Text] [Related]
11. The primitive extratesticular seminoma: diagnosis of a rare pathology.
Saba L
Acta Biomed; 2017 Apr; 88(1):82-85. PubMed ID: 28467339
[TBL] [Abstract] [Full Text] [Related]
12. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
[TBL] [Abstract] [Full Text] [Related]
13. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
[TBL] [Abstract] [Full Text] [Related]
14. [CCAFU Recommendations 2013: testicular germ cell cancer].
Durand X; Rigaud J; Avancès C; Camparo P; Fléchon A; Murez T; Sèbe P; Culine S; Iborra F; Mottet N; Coloby P; Soulié M;
Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
[TBL] [Abstract] [Full Text] [Related]
15. testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
[TBL] [Abstract] [Full Text] [Related]
16. Hook wire localization for testis sparing surgery.
Ong TA; Yaakup NA; Sivalingam S; Razack AH
Urology; 2013 Apr; 81(4):904-7. PubMed ID: 23537760
[TBL] [Abstract] [Full Text] [Related]
17. [Tumour registry and reality: differential diagnosis of testicular tumours in childhood: survey and personal experience].
Ebert AK; Neisser C; Rösch WH
Aktuelle Urol; 2012 Mar; 43(2):104-11. PubMed ID: 22454262
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
[TBL] [Abstract] [Full Text] [Related]
19. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian testicular cancer Group.
Olofsson SE; Tandstad T; Jerkeman M; Dahl O; Ståhl O; Klepp O; Bremnes RM; Cohn-Cedermark G; Langberg CW; Laurell A; Solberg A; Stierner U; Wahlqvist R; Wijkström H; Anderson H; Cavallin-Ståhl E
J Clin Oncol; 2011 May; 29(15):2032-9. PubMed ID: 21482994
[TBL] [Abstract] [Full Text] [Related]
20. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
Krege S; Albers P; Heidenreich A
Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
[TBL] [Abstract] [Full Text] [Related]
[Next]
